CDT Equity (CDT) vs Lakewood-Amedex Biotherapeutics (LABT)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Lakewood-Amedex Biotherapeutics is the larger company by market cap ($1.9 million vs $32,432), about 57.9 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CDT | LABT |
|---|---|---|
| Share price | $0.80 | $0.792 |
| Market cap | $32.43K | $1.88M |
| 1-day change | -4.31% | -6.80% |
| P/E ratio (TTM) | 0.00 | — |
| EPS (TTM) | $90,812.50 | $-8.83 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $28,400.00 | $98.20 |
| 52-week low | $0.796 | $0.76 |
| Distance from 52-week high | -100.00% | -99.19% |
| Analyst consensus | — | strong_buy |
| Avg. price target upside | — | +1415.15% |
| Average volume | 188.27K | 2.50M |
| Shares outstanding | 40.54K | 2.37M |
| Employees | 4 | 5 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Lakewood-Amedex Biotherapeutics is about 57.9 times larger than CDT Equity by market value ($1.88M vs $32.43K).
About CDT Equity
CDT stock →CDT Equity Inc., a data-driven biopharmaceutical company, focuses on identifying, enhancing, and monetising therapeutic assets. The company's pipeline includes AZD1656, a glucokinase activator that is in Phase II trials for the treatment of autoimmune disorders, including uveitis, Hashimoto's thyroiditis, preterm labor, and renal transplant; AZD5658, which is in Phase I clinical trial for the treatment of Type 2 Diabetes Mellitus; and AZD5904, which has completed Phase I clinical trials for the treatment of idiopathic male infertility.
Health Care · Biotechnology: Pharmaceutical Preparations · 4 employees
About Lakewood-Amedex Biotherapeutics
LABT stock →Lakewood-Amedex Biotherapeutics, Inc. operates as a clinical-stage biotechnology company that develops antimicrobial products in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 5 employees
CDT vs LABT FAQ
Which is bigger, CDT Equity or Lakewood-Amedex Biotherapeutics?
Lakewood-Amedex Biotherapeutics (LABT) is larger, with a market capitalization of $1.88M compared with $32.43K for CDT Equity (CDT).
Are CDT Equity and Lakewood-Amedex Biotherapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.